In a Bloomberg Law article, life sciences regulatory & compliance partner Joshua Oyster discussed how the booming market for drugs to treat diabetes and weight loss has triggered lawsuits and complaints from drugmakers and the Food and Drug Administration targeting companies selling unauthorized versions of the products.
“Some of these situations can be a bit of a whack-a-mole game, where there may not be just one entity that is doing this and making an alleged knockoff … there may be a handful or a dozen,” Joshua said.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.